Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Gary Archer
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Living Beings
Procedures
Anatomy
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
49
Bigner, Darell
33
Sampson, John
24
Friedman, Henry
20
McLendon, Roger
17
Zalutsky, Michael
14
Friedman, Allan
11
Heimberger, Amy
10
Wikstrand, Carol
10
Mitchell, Duane
9
Fuchs, Herbert
8
Pastan, Ira
6
Garg, Pradeep
6
Herndon, James
6
Ochiai, Hidenobu
5
Hale, Laura
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Gary Archer (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Sampson John H; Archer Gary E; Mitchell Duane A; Heimberger Amy B; Herndon James E; Lally-Goss Denise; McGehee-Norman Sharon; Paolino Alison; Reardon David A; Friedman Allan H; Friedman Henry S; Bigner Darell D
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.
Molecular cancer therapeutics 2009;8(10):2773-9.
-
2009: Choi Bryan D; Archer Gary E; Mitchell Duane A; Heimberger Amy B; McLendon Roger E; Bigner Darell D; Sampson John H
EGFRvIII-targeted vaccination therapy of malignant glioma.
Brain pathology (Zurich, Switzerland) 2009;19(4):713-23.
-
2008: Schmittling Robert J; Archer Gary E; Mitchell Duane A; Heimberger Amy; Pegram Charles; Herndon James E; Friedman Henry S; Bigner Darell D; Sampson John H
Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.
Journal of immunological methods 2008;339(1):74-81.
-
2008: Sampson John H; Archer Gary E; Mitchell Duane A; Heimberger Amy B; Bigner Darell D
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.
Seminars in immunology 2008;20(5):267-75.
-
2008: Kong Ling-Yuan; Abou-Ghazal Mohamed K; Wei Jun; Chakraborty Arup; Sun Wei; Qiao Wei; Fuller Gregory N; Fokt Izabela; Grimm Elizabeth A; Schmittling Robert J; Archer Gary E; Sampson John H; Priebe Waldemar; Heimberger Amy B
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5759-68.
-
2008: Sampson John H; Akabani Gamal; Archer Gerald E; Berger Mitchel S; Coleman R Edward; Friedman Allan H; Friedman Henry S; Greer Kim; Herndon James E; Kunwar Sandeep; McLendon Roger E; Paolino Alison; Petry Neil A; Provenzale James M; Reardon David A; Wong Terence Z; Zalutsky Michael R; Pastan Ira; Bigner Darell D
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.
Neuro-oncology 2008;10(3):320-9.
-
2008: Heimberger Amy B; Sun Wei; Hussain S Farzana; Dey Mahua; Crutcher Lamonne; Aldape Ken; Gilbert Mark; Hassenbusch Samuel J; Sawaya Raymond; Schmittling Bob; Archer Gary E; Mitchell Duane A; Bigner Darell D; Sampson John H
Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study.
Neuro-oncology 2008;10(1):98-103.
-
2008: Ochiai Hidenobu; Archer Gary E; Herndon James E; Kuan Chien-Tsun; Mitchell Duane A; Bigner Darell D; Pastan Ira H; Sampson John H
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells.
Cancer immunology, immunotherapy : CII 2008;57(1):115-21.
-
2007: Fecci Peter E; Ochiai Hidenobu; Mitchell Duane A; Grossi Peter M; Sweeney Alison E; Archer Gary E; Cummings Thomas; Allison James P; Bigner Darell D; Sampson John H
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2158-67.
-
2006: Learn Chris A; Fecci Peter E; Schmittling Robert J; Xie Weihua; Karikari Isaac; Mitchell Duane A; Archer Gary E; Wei ZhengZheng; Dressman Holly; Sampson John H
Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7306-15.
-
2006: Ochiai Hidenobu; Pernell Chris T; Archer Gary E; Chewning Tracy A; McLendon Roger E; Friedman Henry S; Sampson John H
Treatment of neoplastic meningitis with intrathecal 9-nitro-camptothecin.
Neurologia medico-chirurgica 2006;46(10):485-9; discussion 489-90.
-
2006: Fecci Peter E; Mitchell Duane A; Whitesides John F; Xie Weihua; Friedman Allan H; Archer Gary E; Herndon James E; Bigner Darell D; Dranoff Glenn; Sampson John H
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.
Cancer research 2006;66(6):3294-302.
-
2006: Ochiai Hidenobu; Campbell Stephanie A; Archer Gary E; Chewning Tracy A; Dragunsky Eugenia; Ivanov Alexander; Gromeier Matthias; Sampson John H
Targeted therapy for glioblastoma multiforme neoplastic meningitis with intrathecal delivery of an oncolytic recombinant poliovirus.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1349-54.
-
2004: Ochiai Hidenobu; Moore Stephanie A; Archer Gary E; Okamura Tatsunori; Chewning Tracy A; Marks Jeffrey R; Sampson John H; Gromeier Matthias
Treatment of intracerebral neoplasia and neoplastic meningitis with regional delivery of oncolytic recombinant poliovirus.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4831-8.
-
2004: Learn Chris A; Hartzell Tristan L; Wikstrand Carol J; Archer Gary E; Rich Jeremy N; Friedman Allan H; Friedman Henry S; Bigner Darell D; Sampson John H
Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3216-24.
-
2003: Grossi Peter M; Ochiai Hidenobu; Archer Gary E; McLendon Roger E; Zalutsky Michael R; Friedman Allan H; Friedman Henry S; Bigner Darell D; Sampson John H
Efficacy of intracerebral microinfusion of trastuzumab in an athymic rat model of intracerebral metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(15):5514-20.
-
2003: Sampson John H; Akabani Gamal; Archer Gary E; Bigner Darell D; Berger Mitchel S; Friedman Allan H; Friedman Henry S; Herndon James E; Kunwar Sandeep; Marcus Steve; McLendon Roger E; Paolino Alison; Penne Kara; Provenzale James; Quinn Jennifer; Reardon David A; Rich Jeremy; Stenzel Timothy; Tourt-Uhlig Sandra; Wikstrand Carol; Wong Terence; Williams Roger; Yuan Fan; Zalutsky Michael R; Pastan Ira
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors.
Journal of neuro-oncology 2003;65(1):27-35.
-
2003: Heimberger Amy B; Crotty Laura E; Archer Gary E; Hess Kenneth R; Wikstrand Carol J; Friedman Allan H; Friedman Henry S; Bigner Darell D; Sampson John H
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4247-54.
-
2003: Fecci Peter E; Mitchell Duane A; Archer Gary E; Morse Michael A; Lyerly H Kim; Bigner Darell D; Sampson John H
The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors.
Journal of neuro-oncology 2003;64(1-2):161-76.
-
2002: Heimberger Amy B; Learn Chris A; Archer Gary E; McLendon Roger E; Chewning Tracy A; Tuck Frank L; Pracyk John B; Friedman Allan H; Friedman Henry S; Bigner Darell D; Sampson John H
Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa).
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3496-502.
-
2002: Lal Anita; Glazer Chad A; Martinson Holly M; Friedman Henry S; Archer Gary E; Sampson John H; Riggins Gregory J
Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.
Cancer research 2002;62(12):3335-9.
-
2002: Heimberger Amy B; Archer Gary E; Crotty Laura E; McLendon Roger E; Friedman Allan H; Friedman Henry S; Bigner Darell D; Sampson John H
Dendritic cells pulsed with a tumor-specific peptide induce long-lasting immunity and are effective against murine intracerebral melanoma.
Neurosurgery 2002;50(1):158-64; discussion 164-6.
-
2000: Kuan C T; Wikstrand C J; Archer G; Beers R; Pastan I; Zalutsky M R; Bigner D D
Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv.
International journal of cancer. Journal international du cancer 2000;88(6):962-9.
-
2000: Heimberger A B; Archer G E; McLendon R E; Hulette C; Friedman A H; Friedman H S; Bigner D D; Sampson J H
Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):4148-53.
-
2000: Sampson J H; Crotty L E; Lee S; Archer G E; Ashley D M; Wikstrand C J; Hale L P; Small C; Dranoff G; Friedman A H; Friedman H S; Bigner D D
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(13):7503-8.
-
2000: Heimberger A B; Crotty L E; Archer G E; McLendon R E; Friedman A; Dranoff G; Bigner D D; Sampson J H
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.
Journal of neuroimmunology 2000;103(1):16-25.
-
1999: Archer G E; Sampson J H; Lorimer I A; McLendon R E; Kuan C T; Friedman A H; Friedman H S; Pastan I H; Bigner D D
Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2646-52.
-
1999: McLendon R E; Archer G E; Larsen R H; Akabani G; Bigner D D; Zalutsky M R
Radiotoxicity of systemically administered 211At-labeled human/mouse chimeric monoclonal antibody: a long-term survival study with histologic analysis.
International journal of radiation oncology, biology, physics 1999;45(2):491-9.
-
1999: Kuan C T; Reist C J; Foulon C F; Lorimer I A; Archer G; Pegram C N; Pastan I; Zalutsky M R; Bigner D D
125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1539-49.
-
1999: Sampson J H; Archer G E; Villavicencio A T; McLendon R E; Friedman A H; Bishop W R; Bigner D D; Friedman H S
Treatment of neoplastic meningitis with intrathecal temozolomide.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1183-8.
-
1999: Archer G E; Sampson J H; McLendon R E; Friedman A H; Colvin O M; Rose M; Sands H; McCullough W; Fuchs H E; Bigner D D; Friedman H S
Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats.
Journal of neuro-oncology 1999;44(3):233-41.
-
1998: Ashley D M; Sampson J H; Archer G E; Hale L P; Bigner D D
Local production of TGF beta1 inhibits cerebral edema, enhances TNF-alpha induced apoptosis and improves survival in a murine glioma model.
Journal of neuroimmunology 1998;86(1):46-52.
-
1998: Wikstrand C J; Reist C J; Archer G E; Zalutsky M R; Bigner D D
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.
Journal of neurovirology 1998;4(2):148-58.
-
1997: Sampson J H; Ashley D M; Archer G E; Fuchs H E; Dranoff G; Hale L P; Bigner D D
Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion.
Neurosurgery 1997;41(6):1365-72; discussion 1372-3.
-
1997: Ashley D M; Sampson J H; Archer G E; Batra S K; Bigner D D; Hale L P
A genetically modified allogeneic cellular vaccine generates MHC class I-restricted cytotoxic responses against tumor-associated antigens and protects against CNS tumors in vivo.
Journal of neuroimmunology 1997;78(1-2):34-46.
-
1997: Archer G E; Sampson J H; Bigner D D
Viruses and oncogenes in brain tumors.
Journal of neurovirology 1997;3 Suppl 1():S76-7.
-
1997: Reist C J; Archer G E; Wikstrand C J; Bigner D D; Zalutsky M R
Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Cancer research 1997;57(8):1510-5.
-
1996: Sampson J H; Archer G E; Ashley D M; Fuchs H E; Hale L P; Dranoff G; Bigner D D
Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(19):10399-404.
-
1996: Zalutsky M R; Archer G E; Garg P K; Batra S K; Bigner D D
Chimeric anti-tenascin antibody 81C6: increased tumor localization compared with its murine parent.
Nuclear medicine and biology 1996;23(4):449-58.
-
1996: McLendon R E; Archer G E; Garg P K; Bigner D D; Zalutsky M R
Radiotoxicity of systematically administered [211At]astatide in B6C3F1 and BALB/c (nu/nu) mice: a long-term survival study with histologic analysis.
International journal of radiation oncology, biology, physics 1996;35(1):69-80.
-
1996: Zalutsky M R; Schuster J M; Garg P K; Archer G E; Dewhirst M W; Bigner D D
Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;141():101-22.
-
1995: Bigner D D; Archer G E; McLendon R E; Friedman H S; Fuchs H E; Pai L H; Herndon J E; Pastan I H
Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(12):1545-55.
-
1995: Reist C J; Archer G E; Kurpad S N; Wikstrand C J; Vaidyanathan G; Willingham M C; Moscatello D K; Wong A J; Bigner D D; Zalutsky M R
Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
Cancer research 1995;55(19):4375-82.
-
1995: Kurpad S N; Friedman H S; Archer G E; McLendon R E; Petros W M; Fuchs H E; Guaspari A; Bigner D D
Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.
Cancer research 1995;55(17):3803-9.
-
1995: Pastan I H; Archer G E; McLendon R E; Friedman H S; Fuchs H E; Wang Q C; Pai L H; Herndon J; Bigner D D
Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):2765-9.
-
1994: Page R L; Garg P K; Garg S; Archer G E; Bruland O S; Zalutsky M R
PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(9):1506-13.
-
1994: Zalutsky M R; McLendon R E; Garg P K; Archer G E; Schuster J M; Bigner D D
Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate.
Cancer research 1994;54(17):4719-25.
-
1994: Friedman H S; Archer G E; McLendon R E; Schuster J M; Colvin O M; Guaspari A; Blum R; Savina P A; Fuchs H E; Bigner D D
Intrathecal melphalan therapy of human neoplastic meningitis in athymic nude rats.
Cancer research 1994;54(17):4710-4.
-
1994: He X; Archer G E; Wikstrand C J; Morrison S L; Zalutsky M R; Bigner D D; Batra S K
Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin.
Journal of neuroimmunology 1994;52(2):127-37.
-
1993: Wikstrand C J; Stanley S D; Humphrey P A; Pegram C N; Archer G E; Kurpad S; Shibuya M; Bigner D D
Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas.
Journal of neuroimmunology 1993;46(1-2):165-73.
-
1993: Schuster J M; Friedman H S; Archer G E; Fuchs H E; McLendon R E; Colvin O M; Bigner D D
Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.
Cancer research 1993;53(10 Suppl):2338-43.
-
1991: Humphrey P A; Gangarosa L M; Wong A J; Archer G E; Lund-Johansen M; Bjerkvig R; Laerum O D; Friedman H S; Bigner D D
Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.
Biochemical and biophysical research communications 1991;178(3):1413-20.
-
1990: Humphrey P A; Wong A J; Vogelstein B; Zalutsky M R; Fuller G N; Archer G E; Friedman H S; Kwatra M M; Bigner S H; Bigner D D
Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(11):4207-11.
-
1990: Colapinto E V; Zalutsky M R; Archer G E; Noska M A; Friedman H S; Carrel S; Bigner D D
Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
Cancer research 1990;50(6):1822-7.
-
1990: Fuchs H E; Archer G E; Colvin O M; Bigner S H; Schuster J M; Fuller G N; Muhlbaier L H; Schold S C; Friedman H S; Bigner D D
Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis.
Cancer research 1990;50(6):1954-9.
-
1989: Garg P K; Archer G E; Bigner D D; Zalutsky M R
Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling.
International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes 1989;40(6):485-90.
Sign-in to see more
